No Detail Found!

Comparison of Efficacy of Spironolactone Plus Oral Contraceptives with Metformin in Patients of PCOS with Hirsutism.

Author(s)
Sadia Malik Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Zafar Iqbal Sheikh Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Sameena Kausar Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Najia Ahmed Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To compare the efficacy of spironolactone plus oral contraceptives with metformin in treatment of hirsutism among patients with polycystic ovarian syndrome (PCOS). Study Design: Randomized controlled trial. Place and Duration of Study: Dermatology department, Military Hospital Rawalpindi, from Jan 2016 to Jul 2016. Material and Methods: A total of 84 women with PCOS and hirsutism with ages ranging between 16 and 50 years were included in the study. Patients with hirsutism due to etiologies other than PCOS like idiopathic hirsutism, Cushing syndrome or late-onset congenital adrenal hyperplasia were excluded. Random allocation of treatment was done, those reporting on even dates were enrolled in group A and those reporting on odd dates were placed in group B. Group A received oral tablet spironolactone 50mg twice a day along with combined oral contraceptive pills (cOCPs) containing levonorgestrel 0.15mg / ethinyl estradiol 0.03mg daily as combination therapy for 6 months, while group B received oral metformin 500mg twice daily for 6 months. Hirsutism scores were determined according to the modified Ferriman-Gallwey (mFG) scoring system (attached as annexure A) and 50% reduction from the baseline was considered effective therapeutic response. Results: The mean age of patients in group A was 32.83 ± 8.28 years and in group B was 32.57 ± 8.21 years. The mean duration of disease in group A was 18.84 ± 7.26 months and in group B was 18.04 ± 7.11 months. Efficacy in group A was observed in 29 (69.05%) patients while in group B it was observed in 17 (40.48%) patients. Conclusion: The efficacy of spironolactone plus cOCPs combination therapy is better than metformin alone in the treatment of hirsutism among patients of PCOS.
Publication Details
Page(s) 460-465
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 68, Issue: 3, Year: 2018

Request the full text from PASTIC

References
NathanN,SullivanSD, 2014.The utility of metformin therapy in reproductive aged women with Polycystic Ovary Syndrome (PCOS),Curr Pharm Biotechnol 15 70 -83
EhrmannDA,LongoDA,FauciAS,KasperD, 2012.Hirsutism and virilization,Harrisons's Principles of Medicine, 18th Edn 380 4 -
RahnamaZ,SohbatiS,SafizadehH, 2013.Effect of hirsutism on quality of life: A study in Iranian women,J Pak Assoc Derma 23 28 -33
SahinSB,YucelAF,BedirR,OgullarS,AyazT,AlgunE, 2014.Testosterone and cortisol-secreting adrenocortical oncocytoma: An unusual cause of hirsutism,Case Rep Endocrinol 206890 -
RamezaniTF,MinooeeS, 2014.Validation of a simplified method to assess hirsutism in the Iranian population,Eur J Obstet Gynecol Reprod Biol 174 91 -5
EsmaeilzadehS,AndariehMG,GhadimiR,DelavarMA, 2015.Body Mass Index and Gonadotropin Hormones (LH & FSH) Associate With clinical symptoms among women with polycystic ovary syndrome,Glob J Health Sci 7 101 -106
FranksS., 2012.The investigation and management of hirsutism,J Fam Plan Reprod Health Care 38 182 -6
YacoubSE, 2011.Reduction of diameter of hair shaft among women with hirsutism,Global J Health 3 135 -41
JyotiAB,BhosleD,KadamR, 2014.Comparison of efficacy and safety of metformin, oral contraceptive combination of ethinyl estradiol and drospirenone alone or in combination in polycystic ovarian syndrome,J Obes Metab Res 2 112 -7
GanieMA,KhuranaML,NisarS,ShahPA,ShahZA,KulshresthaB, 2013.Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): A six-month open-label randomized study,J Clin Endocrinol Metab 98 3599 -607
EhrmannDA, 2005.Polycystic ovary syndrome,N Engl J Med 352 1223 -36
LoboRA,ShoupeD,SerafiniP,BrintonD,HortonR., 1985.The effects of two doses of spironolactone on serum androgens and anagen hair in hirsute women,Fertil Steril 43 200 -205
SpritzerPM,LisboaKO,MattielloS, 2000.Spironolactone as a single agent for long-term therapy of hirsute patients,Clin Endocrinol (Oxf) 52 587 -94
LegroR,ArslanianSA,EhrmannDA,HoegerKM,MuradMH,PasqualiR, 2013.Diagnosis and treatment of polycystic ovary syndrome: An endocrine society clinical practice guideline,J Clin Endocrinol Metab 98 4565 -92
KellyCJ,GordonD., 2002.The effect of metformin on hirsutism in polycystic ovary syndrome,Eur J Endocrinol 147 217 -21
DiriH,KaraburguS,AcmazB,UnluhizarciK,TanriverdiF,KaracaZ, 2016.Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome,Gynecol Endocrinol 32 42 -5
OnerG,MuderrisII, 2011.A prospective randomized trial comparing low dose ethinyl estradiol and drospirenone 24/4 combined oral contraceptive vs. ethinyl estradiol and drospirenone 21/7 combined oral contraceptive in the treatment of hirstutism,Contraception 84 508 -11
LeelaphiwatS,JongwutiwesT,LertvikoolS,TabcharoenC,SukprasertM,RattanasiriS,WeerakietS., 2015.Comparison of desogestrel/ethinyl estradiol plus spironolactone versus cyproterone acetate/ethinyl estradiol in the treatment of polycystic ovary syndrome: A randomized controlled trial,J Obstet Gynaecol Res 41 402 -10
El MaghrabyHA,NafeeT,GuiziryD,ElnasharA, 2015.Randomized controlled trial of the effects of metformin versus combined oral contraceptives in adolescent PCOS women through a 24 month follow up period,Middle East Fertil Soc J 21 131 -7
0

Citations

0

Downloads

86

Views